On the other hand, in a mouse model for metastatic lung tumor, systemic administration of IL-33 induced the expansion of IL-5-producing ILC2s, which recruited and sustained eosinophils, critically contributing to increased tumor cell death, and thus preventing metastasis [152]. This evidence concerns the gene IL5 and neoplasm.